1.
Zh Nevrol Psikhiatr Im S S Korsakova
; 122(9): 128-131, 2022.
Artículo
en Ruso
| MEDLINE | ID: covidwho-2056581
RESUMEN
The literature reports that cerebral venous thrombosis (CVT) develops in 1-1.5% of patients with COVID-19. Recently, a new syndrome named vaccine-induced immune thrombotic thrombocytopenia (VITT) has been described. VITT is a rare side-effect of COVID-19 vaccination that also causes CVT. The article presents an overview of the above problem and a clinical case of a patient with CVT that developed within a month after the first component of the Sputnik V vaccination and COVID-19.